personalized, responsive service and to improve the site, we remember and store information about how you use
Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
Welcome to the November issue! Half a million lives have been lost to the US opioid crisis over the past 30 years: our cover feature examines pharma’s role. In Upfront, you can find out how researchers are harnessing bacterial viruses to improve drug delivery to the brain; while Nik Kotecha gives his thoughts on mitigating Brexit supply chain risks in In My View. In Business, Letrishka Anthony asks whether ADCs could finally move to the forefront in the targeted therapy space; and we Sit Down With Tony Hitchcock, Technical Director of Cobra Biologics, Keele, UK.